Latest News in the pharma Industry

Biopharma News

Sandoz strengthens its biosimilars portfolio with acquisition of Pfizer's biosimilar infliximab in EEA

Sandoz strengthens its biosimilars portfolio with acquisition of Pfizer's biosimilar infliximab in EEA

12 Feb 2016

Deal strengthens Novartis immunology portfolio which includes investigational biosimilars adalimumab, etanercept and rituximab.

Read more 
Pfizer commends FDA Advisory Committee’s vote to approve proposed biosimilar infliximab

Pfizer commends FDA Advisory Committee’s vote to approve proposed biosimilar infliximab

10 Feb 2016

The first biosimilar monoclonal antibody reviewed, for all eligible indications.

Read more 
BMS and AbbVie receive positive CHMP opinion for investigational antibody, Empliciti, for the treatment of multiple myeloma

BMS and AbbVie receive positive CHMP opinion for investigational antibody, Empliciti, for the treatment of multiple myeloma

29 Jan 2016

Positive opinion based on reduction in the risk of disease progression or death with Empliciti in combination with standard of care regimen for multiple myeloma demonstrated in ELOQUENT-2 study.

Read more 
Merck announces new biopharma heads for North America and China

Merck announces new biopharma heads for North America and China

28 Jan 2016

Gary Zieziula to head biopharma business in North America and Marc Horn to lead biopharma business in China.

Read more 
Cherwell improves support for pharmaceutical microbiology in Republic of Ireland

Cherwell improves support for pharmaceutical microbiology in Republic of Ireland

28 Jan 2016

Redipor prepared media to be supplied directly to customers.

Read more 
Merck announces FDA acceptance of BLA for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile infection recurrence

Merck announces FDA acceptance of BLA for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile infection recurrence

27 Jan 2016

FDA grants Priority Review with target action date of 23 July 23 2016.

Read more 
Biological drugs market set to grow at a CAGR of 10.10% to reach US$287.1 billion by 2020

Biological drugs market set to grow at a CAGR of 10.10% to reach US$287.1 billion by 2020

27 Jan 2016

Transparency Market Research has announced the publication of a new report, titled "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020".

Read more 
Sartorius Stedim Biotech launches Integrated Solutions online resource center

Sartorius Stedim Biotech launches Integrated Solutions online resource center

26 Jan 2016

New website will support clients in developing and implementing entire single-use bioprocesses.

Read more 
Albumedix and Eleven Biotherapeutics announce albumin variant technology agreement

Albumedix and Eleven Biotherapeutics announce albumin variant technology agreement

26 Jan 2016

Albumedix strengthens its leading position in albumin-based drug delivery through acquisition of Eleven's Supermin albumin technology.

Read more 
Novozymes separates its biopharma activities to form independent company

Novozymes separates its biopharma activities to form independent company

26 Jan 2016

The new stand-alone company Albumedix will continue to develop albumin-based products and technologies for the pharmaceutical industry.

Read more 
Sartorius Stedim Biotech presents new crossflow filtration system for process development

Sartorius Stedim Biotech presents new crossflow filtration system for process development

21 Jan 2016

The ideal solution for scaling studies and low volume ultra- and diafiltration operations.

Read more 
Lonza expands single-use manufacturing capacity in Slough facility to meet customer demand

Lonza expands single-use manufacturing capacity in Slough facility to meet customer demand

13 Jan 2016

Lonza adds two 1000-L single-use bioreactor systems to its current mammalian manufacturing capacity.

Read more